104 related articles for article (PubMed ID: 19137840)
1. Prevalence of abnormal serum alanine aminotransferase levels in type 2 diabetic patients in Iran.
Meybodi MA; Afkhami-Ardekani M; Rashidi M
Pak J Biol Sci; 2008 Sep; 11(18):2274-7. PubMed ID: 19137840
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China.
Chen S; Guo X; Chen Y; Dong S; Sun Y
Postgrad Med; 2016 Nov; 128(8):770-776. PubMed ID: 27681272
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus.
Judi L; Toukan A; Khader Y; Ajlouni K; Khatib MA
Ann Saudi Med; 2010; 30(1):25-32. PubMed ID: 20103955
[TBL] [Abstract][Full Text] [Related]
4. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus.
Farshadpour F; Taherkhani R; Ravanbod MR; Eghbali SS
Med Princ Pract; 2018; 27(4):308-316. PubMed ID: 29621783
[TBL] [Abstract][Full Text] [Related]
6. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem.
Belkacemi L; Belalia M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S147-50. PubMed ID: 26711007
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidaemia is common among patients with type 2 diabetes: a cross-sectional study at Tema Port Clinic.
Ofori EK; Owusu-Ababio D; Tagoe EA; Asare-Anane H
BMC Res Notes; 2019 Apr; 12(1):204. PubMed ID: 30944035
[TBL] [Abstract][Full Text] [Related]
10. Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men.
Villegas R; Xiang YB; Elasy T; Cai Q; Xu W; Li H; Fazio S; Linton MF; Raiford D; Zheng W; Shu XO
Metab Syndr Relat Disord; 2011 Aug; 9(4):305-11. PubMed ID: 21495862
[TBL] [Abstract][Full Text] [Related]
11. AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.
Liu Y; Zhao P; Cheng M; Yu L; Cheng Z; Fan L; Chen C
Lipids Health Dis; 2018 Dec; 17(1):275. PubMed ID: 30509277
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.
Nadeau KJ; Klingensmith G; Zeitler P
J Pediatr Gastroenterol Nutr; 2005 Jul; 41(1):94-8. PubMed ID: 15990637
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
[TBL] [Abstract][Full Text] [Related]
14. Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.
Khedmat H; Fallahian F; Abolghasemi H; Hajibeigi B; Attarchi Z; Alaeddini F; Holisaz MT; Pourali M; Sharifi S; Zarei N
World J Gastroenterol; 2007 Feb; 13(6):889-94. PubMed ID: 17352018
[TBL] [Abstract][Full Text] [Related]
15. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
[TBL] [Abstract][Full Text] [Related]
16. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.
Forlani G; Di Bonito P; Mannucci E; Capaldo B; Genovese S; Orrasch M; Scaldaferri L; Di Bartolo P; Melandri P; Dei Cas A; Zavaroni I; Marchesini G
J Endocrinol Invest; 2008 Feb; 31(2):146-52. PubMed ID: 18362506
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
[TBL] [Abstract][Full Text] [Related]
20. Association between AST/ALT ratio and diabetic retinopathy risk in type 2 diabetes: a cross-sectional investigation.
Li X; Hao W; Lin S; Yang N
Front Endocrinol (Lausanne); 2024; 15():1361707. PubMed ID: 38633757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
